Coldstream Capital Management Inc Vaxcyte, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,231 shares of PCVX stock, worth $38,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,231Holding current value
$38,887% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
342Shares Held
130MCall Options Held
466KPut Options Held
138K-
Vanguard Group Inc Valley Forge, PA12MShares$380 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$372 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$314 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$274 Million11.52% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$203 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $1.87B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...